Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Bullboard Posts
Comment by LogicArchaicon Aug 14, 2015 2:50pm
165 Views
Post# 24019658

RE:Message to Pantalony and the BOD

RE:Message to Pantalony and the BOD
To be fair, they have only recently completed the lumisort prototype, so to all of a sudden expect a partnership right away is silly, especially after patent issues in the past. Also as they mentioned clearly, there has been multiple potential partners who approached them. The stock option stuff is the only way to pay their employees, that being said you are right in the long run. They MUST address this now. As these warrant and option practices are hurting the reputation of the company, and shareholders will punish management by tanking the share price if this continues. The pipeline partnership is most likely inevitable, but we need to combine this with transparency and the ending of penny stock tactics. Warrants are BS, we all know this, and so are excessive stock options to pay management. So while you're wrong about the company selling hope exclusively, you're also right that they must start behaving like a reputable company.
Bullboard Posts